Indefinite Delivery Contract 75A50118D00016

Award Date 6/4/18
Last Date to Order 9/7/24
Awardee
Cue Inc.
Ultimate Awardee
Not listed
Federal Contract Vehicle
Pricing Type
Cost No Fee
Legislative Mandate
Clinger Cohen Act
National Interest Action
None
Award Type
Single
Primary Consortia Member
Not listed
Similar IDVs
The Department of the Army Acquisition Support Center Joint PEO Chemical and Biological Defense awarded an Other Transaction IDV to Cue Inc. on October 13, 2020. With a potential value of $480.9 million, this IDV aims to procure COVID-19 COVID 19 RAPID TEST KITs in support of the agency's pandemic response efforts. As an Other Transaction, no set-aside requirements applied to the award. Under this IDV, Cue Inc. will serve as the prime contractor to deliver COVID-19 rapid antigen test kits to the...
The Defense Logistics Agency Troop Support Medical has awarded a single-award, $49.5 million indefinite-delivery/indefinite-quantity (IDIQ) contract to Cue Health Inc. of San Diego, California to provide laboratory supplies and COVID-19 diagnostic tests over a 5-year period. The original solicitation sought to establish long-term IDIQ contracts for various laboratory supplies and equipment ordered through the DLA Electronic Catalog for delivery to DoD and federal customers. Under this...
The Defense Logistics Agency Troop Support Medical has awarded a single-award indefinite delivery contract to Quidel Corp, a manufacturer of medical diagnostics and supplies, to provide QuickVue At-Home Over-The-Counter COVID-19 test kits. The contract has a potential value of $108 million and a period of performance through November 2023. Under this contract, Quidel has received a $54 million firm fixed price delivery order to supply the QuickVue At-Home tests. The tests will be delivered...
The Department of the Army Acquisition Support Center Joint PEO Chemical and Biological Defense awarded Ellume USA LLC, a foreign-owned, self-certified small disadvantaged business, an Other Transaction (OT) Indefinite Delivery Vehicle (IDV) contract valued at up to $283,858,070.93. This OT agreement, which is not subject to the Federal Acquisition Regulation (FAR), was awarded for the procurement of COVID-19 diagnostic testing prototypes to support the national response to the pandemic. As an...
This indefinite delivery contract was awarded by the Defense Logistics Agency Troop Support Medical to the prime contractor Cepheid, a for-profit manufacturer of molecular diagnostic solutions. The contract has a ceiling value of $49,000,000 and a period of performance through December 21, 2026. The contract aims to procure laboratory supplies, including reagents, diagnostics, chemicals, biologicals, apparatus, equipment, and instruments, for use by the Department of Defense, Department of...
This is a single-award Indefinite Delivery Contract (IDC) awarded by the U.S. Department of Veterans Affairs (VA) to Cepheid, a for-profit manufacturer of molecular diagnostic solutions, including tests for infectious diseases. The contract, valued at $900,000.00, is for the provision of SARS-CoV-2, influenza, and respiratory syncytial virus (RSV) test kits. The awarded task order, valued at $197,065.00, is for the delivery of SARS-CoV-2 IgG testing services to the VA's Veterans Integrated...
The Defense Logistics Agency Troop Support Medical awarded a single award Indefinite Delivery Contract to Cepheid, with a potential value of $790,119,750.00, to provide point-of-care nucleic acid amplification tests and analyzers. A $340 million firm fixed price delivery order was issued to Cepheid for their XPERT XPRESS SARS-COV-2/FLU/R tests, to be performed in Sunnyvale, California from April 1, 2022 through January 3, 2023. The originating solicitation sought proposals for multiple...
The Department of Health and Human Services Indian Health Service awarded a single-award, indefinite delivery contract to Cepheid to provide COVID-19 reagents, kits, and laboratory supplies. A $668,056 firm fixed price delivery order was issued against this contract to support the agency's testing efforts through the procurement of Cepheid materials. The delivery order aims to bolster coronavirus diagnostic capabilities at IHS sites through October 2021 by furnishing reagents, kits and...
The Indian Health Service awarded an Agency-Wide Indefinite Delivery/Indefinite Quantity contract to Cepheid to provide laboratory analyzers, testing kits, reagents, and associated support for COVID-19 testing across 177 IHS facilities nationwide. The IDIQ and subsequent delivery orders have a potential value of $128.4 million and contemplate a 12-month base period and four 1-year options. Cepheid will deliver its GeneXpert molecular diagnostic platform along with FDA Emergency Use Authorized...
The federal contract IDV award is a Blanket Purchase Agreement (BPA) master contract between the Defense Health Agency (DHA) and Cepheid Inc., a for-profit manufacturer of molecular diagnostic solutions. The contract has a ceiling value of $8,000,000 and an ultimate completion date of January 24, 2030. Under this single-award BPA, Cepheid provides the DHA with reagents, testing kits, and consumable supplies for molecular diagnostic testing. Key products include GeneXpert diagnostic systems,...

The Department of Health and Human Services Office of the Assistant Secretary for Preparedness and Response awarded a single-award Indefinite Delivery Contract to Cue Inc., a self-certified small disadvantaged business, for the development of a first-in-class reusable platform-based Influenza In Vitro Diagnostic (IVD) test for in-home use. The contract has a potential value of $37,973,619.77 and a period of performance through September 7, 2024. The contracted work aims to develop an innovative, reusable IVD test platform that can be used by consumers in a home setting to detect Influenza. As the funding agency, the Department of Health and Human Services is leveraging this contract to advance the availability of accessible, point-of-care diagnostic capabilities to support public health preparedness and response efforts related to seasonal and pandemic influenza.

Generated 5/2/24, 9:14 AM